Environmental Project, 929 – Valuation of Chemical related Health Impacts - Estimation of direct and indirect costs for asthma bronchiale, headache, contact allergy, lung cancer and skin cancer

Valuation of Chemical related Health Impacts

11 References

AEA Technology (2001). Economic Evaluation of AirQuality Targets for PAHs, Final report for European Commission DG Environment. http://europa.eu.int/comm/environment/enveco/air/pah_report.pdf

Andersen, I.(Editor) (1994). Arbejdsmedicin, bind 1. 1994; København: Arbejdsmiljøinstituttet.

Andersen, Mikael Skou, DMU og Niels Strange, KVL og Forskningscenter Skov og Landskab: Miljøøkonomiske beregningspriser, - forprojekt, 2003 (endnu ikke offentliggjort)

Andersen et al. (1998). Måling af omkostninger ved ressourceforbruget til behandling og pleje af demente ældre i forhold til ikke-demente. CHS Working Paper 1998:6.

Beddingfield, F. C. (2002). Melanoma. A decision analysis to estimate the effectiveness and costs-effectiveness of screening and an analysis of the relevant epidemiology of the disease. PHD dissertation. RAND Graduate School.

Braud, A-C. et al. (2003). Direct treatment costs for patients with lung cancer from first recurrence to death in France. Pharmacoeconomics; 21(9):671-79.

Brouwer, W. et al. (2001). Costing in economic evaluations. In: Drummond, M & McGuire, A. Economic Evaluation in Health Care. Merging Theory with Practive. Oxford University Press.

Chan-Yeung, M. Occupational Asthma. Environmental Health Perspectives, Vol. 103, Supplement 6, pages 249-252, 40 references, 1995

Chen, J. G. et al. (2001). Cost of Nonmelanoma skin cancer treatment in the United States. Dermatol Surg; 27:12:December.

COST 313 (1995), EC - Tansport research: Cost 313 - Socio-ecnonomic cost of road accidents (1994).

COWI: Værdisætning af trafikkens eksterne omkostninger, rapportudkast til Trafikministeriet, 1999

DEPA: Notat om værdisætning af sundhedseffekter, internt notat, 2003

Dombernowsky, P. et al. (1997). Medicinsk behandling af kræftsygdomme. Arbejdsgruppe nedsat af Dansk Selskab for Intern Medicin. Ugeskrift for Læger, nr. 3.

Drzewiecki, K. (2003). Assessment. Personal communication. 26-11-03.

EPA - Cost-of-illness handbook. US Environmental Protection Agency (2002). URL: http://www.epa.gov/oppt/coi/. Accessed on the 18th of August 2003.

Evans C. and Crawford B. (2000). Expert judgement in pharmacoeconomic studies. Guidance and future use. Pharmacoeconomics. 2000 Jun;17(6):545-53.

EU Kommissionen: Assessment of the Impact of the New Chemicals Policy on Occupational Health, RPA, 2003-06-05

Finansministeriet (1999). Vejledning i udarbejdelse af samfundsøkonomiske konsekvensvurderinger.

Friedrich, Rainer and Bickel, Peter: Environmental External Costs of Transport, 2001.

Gundgaard et al. (2002). Vurdering af de sundhedsøkonomiske konsekvenser ved et øget indtag af frugt og grøntsager. Teknisk Rapport. CAST - Center for Anvendt Sundhedstjenesteforskning og Teknologivurdring

Hansen, J. et al. (1998). Risiko for cancer ved arbejde med visse stoffer som er kræftfremkaldende hos dyr. Forskningsrapport. Arbejdsmiljøfondet.

Housman, T. S. et al. (2003). Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol, Vol 48, Number 3; 425- 429.

Hudgson, T. A. (1994). Costs of illness in cost-effectiveness analysis. A review of the methodology. Pharmacoeconomics 6 (6):536-52.

Hudgson, T. A. (1988). Annual costs of illness versus lifetime costs of illness and implications of structural change. Drug information journal, vol. 22, pp.323-41.

The International Classification of Headache Disorders. 2nd Edition (2003). Short title: ICHD-II. Headache Classification Subcommittee of the International Headache Society (HIS).

Johansen, D. J. and Ménné, T. (2003). Personal communication. 10-10-03.

Kidholm, Kristian og Jes Søgaard, Odense Universitet, Centre for Health and Social Policy: Undersøgelse af behandlingsomkostninger ved personskade ved trafikulykker, Arbejdsnotat 1996:1, 1996

Kidholm, Kristian (1995), Odense Universitet, Centre for Health and Social Policy: Estimation af betalingsvilje for forebyggelse af personskader ved trafikulykker, Afhandling fra Odense Universitet, 1995

Krupnick, Alan, Anna Albertini, Maureen Cropper and Nathalie Simon, RFF: Mortality Risk Valuation for Environmental Policy, Discussion paper, 1999

Kræftens bekæmpelse (2003a). Definition af incidens og overlevelsestal. Definition of incidence and survival data (in Danish). http://www.cancer.dk/alt+om+kraeft/fakta+om+kraeft/definition+af+incidens+og+overlevelsestal1.asp. Accessed on the 8/12/03.

Kræftens bekæmpelse (2003b). Behandling af lungkræft. http://www.cancer.dk/alt+om+kraeft/kraeftsygdomme/lunge/behandling+af+lungekraeft1.asp. Accessed on the 10 September 2003.

Kuntz, K., M. & Weinstein, M. C. (2001). Modelling in economic evaluation. In: Drummond, M & McGuire, A. Economic Evaluation in Health Care. Merging Theory with Practive. Oxford University Press.

Lægemiddelstyrelsen (2003). Costs of drugs. Costs per DDD calculated from 'Årsstatisik. Fordelt på alder og køn i den primære sundhedssektor (1998-2002)'. http://www.laegemiddelstyrelsen.dk/statistik/aarsstatistik.asp. Accessed 9-10-03.

Lægemiddelstyrelsen (2001). Forbruget af astmamedicin blandt voksne i Danmark 1998-2000. http://www.laegemiddelstyrelsen.dk/statistik/forbrugsanalyser/astmanotat.asp. Accessed 13-10-03

Mosbech H. (2003). Assessment. Personal Communication. Overlæge, dr. med. Rigshospitalets Allergiklinik. 21-10-03.

Møller F. et el (2000): Samfundsøkonomisk vurdering af miljøprojekter. Danmarks Miljøundersøgelser, Miljøstyrelsen og Skov- og Naturstyrelsen.

Navrud, S, Agricultural University of Norway: Valuing Health Impacts from air pollution in Europe, New Empirical Evidence on Morbidity, Working paper, 1997)

OECD: Technical Guidance Document on the use of Socio-Economic Analysis in Chemical Risk Management Decision Making No. 14, 2002

OECD: Framework for Integrating Socio-Economic Analysis in Chemical Risk Management Decision Making No. 13, 2000

OECD: Guidance for Conducting Retrospective Studies on Socio-Economic Analysis No. 11, 1999

OECD: Proceedings of the OECD Workshop on the Integration of Socio-Economic Analysis in Chemical Risk Management Decision Making, London January 7-9 1998 No. 9, 1999

Olesen, J. (2003). Personal communication. Professor of Neurology. Department of Neurology. Glostrup Hospital. University of Copenhagen. Denmark. 1-10-03.

Olivier, E. et al. (2001). Treatment pathways, resource use and costs in the management of small cell lung cancer. Thorax. Oct;56(10):785-90.

Otterström T., Gynther L., and Vesa P., The willingness to pay for better air quality, Ekono Energy Ldt., 1998.

Pearce: Valuing Risks to Life and Health, Towards Consistent Transfer Estimates in the European Union and Accession States, paper prepared for the EU Commission (DG XI), 2000

Petersen, M. L. and Larsen, T. (2003). Reduktion af radon. En samfundsøkonomisk analyse. Institut for Miljøvurdering. August 2003

Rasmussen, S. R. and Søgaard, J. (2000). Tobaksrygningens samfundsøkonomiske omkostninger. Ugeskrift for læger;162:3329-33

Sonnenberg, F. A. and Leventhal, E. A. (1998). Modelling disease progression with Markov models. Health Economics of Dementia. Edited by Anders Wimo, et al. John Wiley & Sons Ltd.

Sundhedsstyrelsen: Forebyggelse af kontakteksemer, 1998

Sundhedsstyrelsen (2001). Forebyggelse af kontakteksemer. Forebyggelse og Sundhedsfremme. 2001/17. http://www.sst.dk/publ/Publ2001/suke2.pdf. Accessed 1/10/03.

Statistics Denmark (2003a). Expected remaining lifetime. StatBank Denmark. http://www.statistikbanken.dk/statbank5a/SelectVarVal/Define.asp?MainTable=HISB8&PLanguage=0&PXSId=0. Accessed 18-10-03

Statistics Denmark (2003b). Statistisk Årbog 2003

Storm, H. H. and Engholm, G. (2002). Relativ overlevelse for danske kræftpatienter diagnosticeret 1981-1997 og fulgt til 2001. En status. Ugeskrift for læger, 27. maj 2002, nr. 22.

Vejdirektoratet: Trafikøkonomiske enhedspriser for uheld - Alternative metoder til opgørelse af velfærdstabet, Arbejdsnotat udarbejdet af COWI, 2002

Virmani, A. K. et al. (1999). Molecular Abnormalities in lung cancer and their relationship to histological subtypes in: Hirsch, F. R. (Editor). Lung Cancer. Recent developments in diagnosis and treatment.

Sundhedsstyrelsen (2003a). Cancerregisteret 1999. Nye tal fra Sundhedsstyrelsen. Årgang 7. Nr. 2 2003.

Sundhedsstyrelsen (2003b). Kræftstatistik baseret på landspatientregisteret 1998-2002. Nye tal fra Sundhedsstyrelsen. Årgang 7. Nr. 9 2003.

TreeAge (2001). DataPro 4.0 Health Care User's Manual. TreeAge Softeware.

Vogel U, Dybdahl M. Kroppens forsvar mod DNA-skader påvirker kræftrisikoen. Miljø og sundhed,2000;3;12-13